Drag

Dr. Reddy's Laboratories Limited

Healthcare DRREDDY

1236.20INR
53.70 ( 4.54%)

Last update at

Day Range

1218.101265.90
LowHigh

52 Week Range

1013.57 1377.26
LowHigh

Fundamentals

  • Previous Close 1182.50
  • Market Cap 1004813.29M
  • Volume926,173
  • P/E Ratio 17.16
  • EBITDA 88670.00M
  • Revenue TTM 342149.01M
  • Revenue Per Share TTM 410.87
  • Gross Profit TTM 193082.00M
  • Diluted EPS TTM 70.34

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED DRREDDY ₹ 1234.90 23/01/26 23/01/26 Same Day Short Term Healthcare 1.29%
CLOSED DRREDDY ₹ 1319.10 10/06/25 26/06/25 16 Days Mid Term Healthcare 0.11%
CLOSED DRREDDY ₹ 1232.00 6/02/25 6/02/25 Same Day Short Term Healthcare 1.79%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 76784.00M 71870.00M 60485.00M 32298.00M 28324.00M
Net income 56544.00M 55684.00M 45073.00M 23568.00M 19149.00M
Total Revenue 325535.00M 279164.00M 245879.00M 214391.00M 189722.00M
Gross Profit 190428.00M 163607.00M 169302.00M 113840.00M 103077.00M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 492989.00M 387518.00M 322851.00M 296654.00M 265491.00M
Intangible assets 96803.00M 36951.00M 30724.00M 27246.00M 35648.00M
Other current assets 30699.00M 22729.00M 15120.00M 13902.00M 14509.00M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 7486.00M 1328.00M -9073.00M 32.00M 12858.00M
Operating Cash 46428.00M 45433.00M 58873.00M 28108.00M 35703.00M
Free Cash Flow 18924.00M 17998.00M 40009.00M 9059.00M 23142.00M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
DRREDDY
Dr. Reddy's Laboratories Limited 		53.70 4.54% 1236.20 1004813.29 17.16
SUNPHARMA
Sun Pharmaceutical Industries Limited 		75.40 4.63% 1703.30 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		336.50 5.65% 6289.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		39.90 1.00% 4027.10 1362716.66 63.48
CIPLA
Cipla Limited 		16.40 1.25% 1328.00 1183505.97 21.74

Profile

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Dr. Reddy's Laboratories Limited

8-2-337, Road No. 3, Hyderabad, India, 500034

Key Executives

Name Title Year Born
Mr. Gunupati Venkateswara Prasad B.E. Co-Chairman, MD & Member of Management Council 1960
Mr. Kallam Satish Reddy B.Tech., M.S. Chairman & Member of the Management Council 1967
Mr. Erez Israeli M.B.A. CEO & Member of the Management Council 1968
Mr. Parag Agarwal CFO & Member of Management Council 1966
Mr. Deepak Sapra M.B.A. CEO of API & Services & Member of Management Council 1975
Mr. Venkata Ramana Motupalli M.B.A., MBA CEO of Branded Markets - India & Emerging Countries and Member of Management Council 1969
Ms. Archana Bhaskar B.Sc., M.B.A. EVP, Head of Corp. Communications, Chief HR Officer & Member of Management Council 1967
Mr. Sanjay Sharma B.Tech. Exec. VP, Global Head of Global Manufacturing & Member of Management Council 1968
Mr. Marc Kikuchi B.A., M.B.A. CEO of North America Generics & Member of Management Council 1969
Mr. Patrick Aghanian B.A., M.B.A. CEO of European Generics & Member of Management Council 1965

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.